In June 17, 2026, in Sacramento, California, Lunai Bioworks (NASDAQ: LNAI) provided an update to shareholders, highlighting their focus on developing a cutting-edge biotechnology firm that combines artificial intelligence and national interests. This update comes after several months of consistent efforts towards this strategy.